9,670 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by Shelton Capital Management

Shelton Capital Management acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,670 shares of the biotechnology company's stock, valued at approximately $5,747,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Employees Retirement System of Texas bought a new position in Axon Enterprise in the fourth quarter valued at approximately $39,620,000. Federated Hermes Inc. boosted its holdings in shares of Axon Enterprise by 25.8% in the 4th quarter. Federated Hermes Inc. now owns 339,063 shares of the biotechnology company's stock valued at $201,514,000 after purchasing an additional 69,567 shares in the last quarter. Edgewood Management LLC bought a new position in shares of Axon Enterprise in the 4th quarter valued at $2,734,000. Peapack Gladstone Financial Corp raised its holdings in shares of Axon Enterprise by 38.7% during the 4th quarter. Peapack Gladstone Financial Corp now owns 1,222 shares of the biotechnology company's stock worth $726,000 after buying an additional 341 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Axon Enterprise by 2.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,198 shares of the biotechnology company's stock worth $712,000 after buying an additional 25 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AXON has been the subject of several research analyst reports. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC reaffirmed a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $626.45.

Remove Ads

Axon Enterprise Trading Up 2.2 %

Axon Enterprise stock traded up $12.45 during mid-day trading on Monday, hitting $580.43. 196,854 shares of the stock were exchanged, compared to its average volume of 806,258. The stock has a market capitalization of $44.47 billion, a price-to-earnings ratio of 149.98, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm's fifty day simple moving average is $567.07 and its two-hundred day simple moving average is $561.71.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.